Usefulness of serum CA 15.3 and histopathological prognostic indices in breast cancer

Indian Journal of Clinical Biochemistry

Volumn 20, Issue 1, 2005, Pages 165-168

  Nalini, R ^a   Delphine Silvia, C R Wilma ^a   Makhija, Purnima M ^a   Uthappa, Sheila ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Breast Cancer; CA 15.3; Nottingham's Prognostic Index; NPI

Indexed keywords

CA 15-3 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; CHEMICAL ANALYSIS; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NOTTINGHAM PROGNOSTIC INDEX; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

EID: 14944370776     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02893065     Document Type: Article

References (14)

1. Chopra Rakesh (2001) Breast Cancer - The Indian scene. Journal of Clinical Oncology. 19 (18 supplement), 106s-111s
2. Denley H., Pinder S. E., Elston C. W., Lee A. H. S., and Ellis I. O. (2001) Preoperative assessment of prognostic factors in breast cancer. Journal of Clinical Pathology. 54, 20-24
3. Blarney R. W., Davies C. J., Elston C. W., Johnson Jane, Haybittle J. L., and Maynard P. V. (1979) Prognostic factors in breast cancer-the formation of a prognostic index. Clinical Oncology. 5, 227-236
4. Miller W. R., Ellis I. O., Sainsbury J. R. C., and Dixon J. M. (1994) ABC of breast diseases - prognostic factors. British Medical Journal. 309, 1573-1576
5. Haybittle J. L., Blamey R. W., Elston C. W., Johnson J., Doyle P. J., Campbell F. C., Nicholson R. I., and Griffiths K. (1982) A prognostic index in primary breast cancer. British Journal of Cancer. 45, 361-366
6. Galea M. H., Blamey R. W., Elston C. E., and Ellis I. O. (1992) The Nottingham's prognostic index in primary breast cancer. Breast Cancer Research Treatment. 22, 207-219
7. D'Eredita G., Giardina C., Martellotta M., Natale T., and Ferrarese F. (2001) Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. European Journal of Cancer. 37, 591-596
8. Chollet P., Amat S., Belem Bavogo E., Cure H., De Latour M., Dauplat J., Le Bouedec G., Mouret-Reynier M-A., Fernere J-P, and Penault-Llorca F. (2003) Is Nottingham Prognostic Index useful after induction chemotherapy in operable breast cancer?. British Journal of Cancer. 89, 1185-1191
9. Duffy M. J. (2001 ) Biochemical markers in breast cancer: Which ones are clinically useful?. Clinical Biochemistry. 34, 347-352
10. Duffy M. J., Catherine D., Rachel K., Arnold D. K. Hill, Enda M., John Crown, and Niall O'Higgins (2004) High preoperative CA 15.3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: Study of 600 patients with histologically confirmed breast cancer. Clinical Chemistry. 50(3), 559-563
11. Fisher B., Bryant J., Wolmark N., Mamounis E., Brown A., Fisher E. R., Wickerham D. L., Begovic M., Decillis A., Robidoux A., Margolese R. G., Cruz Jr A. B., Hoehn J. L., Lees A. W., Dimitrov N. V., Bear H. D. (1998) Effect of pre-operative chemotherapy on the outcome of women with operable breast cancer. Journal of Clinical Oncology. 16, 2672-2685
12. Giai M., Riccardo, Roagna, Riccardo Ponzone, Nicoletta, Biglia, Luca Sgro, Marco Perona, and Piero Sismondi. (1996) TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients. Anti-cancer Research. 16, 875-882
13. Bon G S., Von Mensdorff-Pouilly S., Kenemans P., Van Kamp G. J., Verstraeten R. A., Hilgers J. (1997). Clinical and technical evaluation of ACS BR serum assay of MUCl gene-derived glycoprotein in breast cancer and comparison with CA 15.3 assay. Clinical Chemistry. 47, 585-593.
14. th edition. 792 pages.